REPL
Replimune Group Inc
Price:  
13.07 
USD
Volume:  
1,309,870.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Relative Valuation

-877.5%
Upside

As of 2026-10-06, the Relative Valuation of Replimune Group Inc (REPL) is (101.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.07 USD, the upside of Replimune Group Inc based on Relative Valuation is -877.5%.

The range of the Relative Valuation is (93.40) - (108.72) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 24.9x - 29.1x 27.0x
Forward P/E multiples 25.0x - 29.8x 27.4x
Fair Price (93.40) - (108.72) (101.62)
Upside -814.6% - -931.8% -877.5%
13.07 USD
Stock Price
(101.62) USD
Fair Price

REPL Relative Valuation - Historical P/E Data

Date P/E
2026-10-02 -3.50
2026-10-01 -3.60
2026-09-30 -3.54
2026-09-29 -3.48
2026-09-28 -3.36
2026-09-25 -3.31
2026-09-24 -3.37
2026-09-23 -3.47
2026-09-22 -3.61
2026-09-21 -3.44
2026-09-18 -3.50
2026-09-17 -3.44
2026-09-16 -3.47
2026-09-15 -3.49
2026-09-14 -3.51
2026-09-11 -3.46
2026-09-10 -3.54
2026-09-09 -3.87
2026-09-08 -3.95
2026-09-04 -4.03
2026-09-03 -4.09
2026-09-02 -4.28
2026-09-01 -4.19
2026-08-31 -4.10
2026-08-28 -4.15
2026-08-27 -4.18
2026-08-26 -4.25
2026-08-25 -4.23
2026-08-24 -3.94
2026-08-21 -3.95
2026-08-20 -3.76
2026-08-19 -3.96
2026-08-18 -4.17
2026-08-17 -3.92
2026-08-14 -4.01
2026-08-13 -4.07
2026-08-12 -4.08
2026-08-11 -3.65
2026-08-10 -3.66
2026-08-07 -3.23
2026-08-06 -3.44
2026-08-05 -3.17
2026-08-04 -3.19
2026-08-03 -3.19
2026-07-31 -3.00
2026-07-29 -1.45
2026-07-28 -1.43
2026-07-27 -2.31
2026-07-24 -2.60
2026-07-23 -2.80